# Martin J. van den Bent

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/martin-j-van-den-bent/

## Facts

| Field | Value |
| --- | --- |
| Citations | 103,006 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 129 |
| i10-index | 519 |
| Last Known Institution | Erasmus MC Cancer Institute |
| OpenAlex ID | https://openalex.org/A5010891460 |
| ORCID iD | https://orcid.org/0000-0001-5710-5127 |
| Works | 1,349 |

## Researcher papers

- [Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial](https://scholariq.org/papers/long-term-efficacy-of-early-versus-delayed-radiotherapy-for-low-grade/)
- [Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma](https://scholariq.org/papers/vorasidenib-in-idh1-or-idh2-mutant-low-grade-glioma/)
- [Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034](https://scholariq.org/papers/randomized-phase-ii-trial-of-erlotinib-versus-temozolomide-or-carmustine-in/)
- [Transcriptome analysis reveals tumor microenvironment changes in glioblastoma](https://scholariq.org/papers/transcriptome-analysis-reveals-tumor-microenvironment-changes-in-glioblastoma/)
- [INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma](https://scholariq.org/papers/intellance-2-eortc-1410-randomized-phase-ii-study-of-depatux-m-alone-and-with/)
- [Cognitive status and quality of life after treatment for primary CNS lymphoma](https://scholariq.org/papers/cognitive-status-and-quality-of-life-after-treatment-for-primary-cns-lymphoma/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

## Researcher university

- [Erasmus MC Cancer Institute](https://scholariq.org/institutions/erasmus-mc-cancer-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.